FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX)

Q3 2021 13F Holders as of 9/30/2021

Type / Class
Equity / GENOMIC ADV ETF
Number of holders
10
Total Shares
274K
Shares change
+194K
Total reported value, excl. options
$14.3M
Value change
+$10.2M
Put/Call ratio
0
Number of buys
5
Number of sells
-5
Price
$52.30
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.